Cellgen is developing a novel precision medicine platform that enables doctors to administer a simple blood test that will determine if a person’s genetic profile is a match for a given therapeutic in 2 hours. This platform will help clinicians guide ongoing treatment decisions to make sure the right person is taking the right medicine. Each disposable test will not only be guided by the genetics of each patient, but also by the latest clinical knowledge on drug metabolism. Cellgen’s decision support and computational algorithms will provide a predictive analysis of the therapeutic effectiveness, where every new patient improves the predictive accuracy. Cellgen’s speed, simplicity and low cost will allow clinicians, to both, administer and process non-invasive, genomic based testing at the point of care. If precision medicine is going to meet its promise and gain broad applicability, genomic technologies will have to meet patients at the point of care and move beyond Oncology.